STOCK TITAN

Incyte to Report Fourth Quarter and Year-End 2023 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Incyte (Nasdaq:INCY) has scheduled its Q4 & YE 2023 financial results conference call and webcast for February 13, 2024. The press release will be at 7:00 a.m. ET, followed by the conference call at 8:00 a.m. ET. The company will provide a domestic and international dial-in number, along with a conference ID number for participation. A replay of the conference call will be available for thirty days, and the webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
Positive
  • None.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2023 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 13, 2024.

The schedule for the press release and conference call/webcast is as follows:

  • Q4 & YE 2023 Press Release: February 13, 2024 at 7:00 a.m. ET
  • Q4 & YE 2023 Conference Call: February 13, 2024 at 8:00 a.m. ET
  • Domestic Dial-In Number: 877-407-3042
  • International Dial-In Number: 201-389-0864
  • Conference ID Number: 13744020

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13744020.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, Twitter, Instagram, Facebook, YouTube.

Incyte Contacts

Media

media@incyte.com

Investors

ir@incyte.com

Source: Incyte

FAQ

When is Incyte's Q4 & YE 2023 financial results conference call and webcast scheduled?

The conference call and webcast are scheduled for February 13, 2024.

What time is the Q4 & YE 2023 press release?

The press release will be at 7:00 a.m. ET on February 13, 2024.

How long will the replay of the conference call be available?

The replay of the conference call will be available for thirty days.

Where can the webcast with slides be accessed?

The webcast with slides can be accessed at Investor.Incyte.com.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON